FDA and the medical device industry : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, second session, February 26, 1990.

Biotechnology development : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first session, December 18, 1985.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 99-53.""Printed for the use of the Committee on Energy and Commerce."Mode of access: Int...

Medical devices : FDA can improve oversight of tracking and recall systems : report to the Subcommittee on Oversight and Investigations, Committee on Commerce, House of Representatives /

United States. General Accounting Office.
United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.

"September 1998"GAO/HEHS-98-211."Cover title.Includes bibliographical references.Mode of access: Int...

FDA medical product approvals : hearing before the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 8, 1995.

United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs.

January 1997

Shipping list no.: 97-0171-P.Distributed to some depository libraries in microfiche.Mode of access: ...

FDA and the medical device industry : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, March 25 and June 3, 1992.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 102-129."Shipping list no.: 92-0515-P.Distributed to some depository libraries in microf...

FDA oversight [microform] : medical devices : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-seventh Congress, second session, July 16, 1982.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.

January 1982

"Serial no. 97-144."CIS Microfiche Accession Numbers: CIS 82 H361-107Includes bibliographical refere...

FDA's drug and device review process : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 6, 1992.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 102-132."Shipping list no.: 92-0573-P.Distributed to some depository libraries in microf...

Clinical laboratories : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, second session, March 10 and July 27, 1988.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.

January 1988

"Serial no. 100-146."Includes bibliographical references.Mode of access: Internet

Medical devices : hearing before the Committee on Labor and Human Resources, United States Senate, One Hundred First Congress, second session, on examining proposed legislation to revise and strengthen the Food and Drug Administration's regulation of medical devices, July 25, 1990.

United States. Congress. Senate. Committee on Labor and Human Resources.

Shipping list no.: 91-209-P.Distributed to some depository libraries in microfiche.Includes bibliogr...

Medical devices : FDA's implementation of the medical device reporting regulation : report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives /

United States. General Accounting Office.
United States. Congress. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

January 1989

"B-223710"--p.[1]"GAO/PEMD-89-10""February 1989"Cover title."References": p.83.Mode of access: Inter...

Food and Drug Administration oversight : hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

"Serial no. 102-116"--Pt. 2."Serial no. 102-25"--Pt. [1]."One Hundred Second Congress, first session...

Medical devices : FDA review time : report to the Chairman, Subcommittee on Oversight and Investigations, Committee on Commerce, House of Representatives /

United States. General Accounting Office.
United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.

"B-261822"--P. 1."GAO/PEMD-96-2.""October 1995."Cover title.Includes bibliographical references.Mode...

Regulating innovation : FDA's medical device approval process : hearing before the Subcommittee on Investigations and Oversight of the Committee on Science, Space, and Technology, U.S. House of Representatives, One Hundred Third Congress, first session, September 17, 1993.

United States. Congress. House. Committee on Science, Space, and Technology. Subcommittee on Investigations and Oversight.

"No. 69."Shipping list no.: 94-0020-P.Distributed to some depository libraries in microfiche.Mode of...

FDA consumer protection activities--FDA reorganization. Hearings, Ninety-first Congress, first and second session ...

United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Public Health and Welfare.

January 1970

Hearings held Aug. 12, 1969-Jan. 29, 1970."Serial no. 91-71."Includes bibliographical references.Mod...

FDA regulation of medical devices, including the status of breast implants : joint hearing before the Subcommittee on Human Resources and Intergovernmental Relations and the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 1, 1995.

United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations.
United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs.

Shipping list no.: 96-0129-P.Distributed to some depository libraries in microfiche.Cover title.Incl...

Clinical laboratories : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session ....

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 102-136"--Pt. 2."Serial no. 102-67"--Pt. [1].Shipping list no.: 92-167-P.Distributed to ...

Biotechnology development : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first session, December 18, 1985.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 99-53.""Printed for the use of the Committee on Energy and Commerce."Mode of access: Int...

Medical devices : FDA can improve oversight of tracking and recall systems : report to the Subcommittee on Oversight and Investigations, Committee on Commerce, House of Representatives /

United States. General Accounting Office.
United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.

"September 1998"GAO/HEHS-98-211."Cover title.Includes bibliographical references.Mode of access: Int...

FDA medical product approvals : hearing before the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 8, 1995.

United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs.

January 1997

Shipping list no.: 97-0171-P.Distributed to some depository libraries in microfiche.Mode of access: ...

FDA and the medical device industry : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, March 25 and June 3, 1992.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 102-129."Shipping list no.: 92-0515-P.Distributed to some depository libraries in microf...

FDA oversight [microform] : medical devices : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-seventh Congress, second session, July 16, 1982.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.

January 1982

"Serial no. 97-144."CIS Microfiche Accession Numbers: CIS 82 H361-107Includes bibliographical refere...

FDA's drug and device review process : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 6, 1992.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 102-132."Shipping list no.: 92-0573-P.Distributed to some depository libraries in microf...

Clinical laboratories : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, second session, March 10 and July 27, 1988.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.

January 1988

"Serial no. 100-146."Includes bibliographical references.Mode of access: Internet

Medical devices : hearing before the Committee on Labor and Human Resources, United States Senate, One Hundred First Congress, second session, on examining proposed legislation to revise and strengthen the Food and Drug Administration's regulation of medical devices, July 25, 1990.

United States. Congress. Senate. Committee on Labor and Human Resources.

Shipping list no.: 91-209-P.Distributed to some depository libraries in microfiche.Includes bibliogr...

Medical devices : FDA's implementation of the medical device reporting regulation : report to the Chairman, Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives /

United States. General Accounting Office.
United States. Congress. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

January 1989

"B-223710"--p.[1]"GAO/PEMD-89-10""February 1989"Cover title."References": p.83.Mode of access: Inter...

Food and Drug Administration oversight : hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.

"Serial no. 102-116"--Pt. 2."Serial no. 102-25"--Pt. [1]."One Hundred Second Congress, first session...

Medical devices : FDA review time : report to the Chairman, Subcommittee on Oversight and Investigations, Committee on Commerce, House of Representatives /

United States. General Accounting Office.
United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.

"B-261822"--P. 1."GAO/PEMD-96-2.""October 1995."Cover title.Includes bibliographical references.Mode...

Regulating innovation : FDA's medical device approval process : hearing before the Subcommittee on Investigations and Oversight of the Committee on Science, Space, and Technology, U.S. House of Representatives, One Hundred Third Congress, first session, September 17, 1993.

United States. Congress. House. Committee on Science, Space, and Technology. Subcommittee on Investigations and Oversight.

"No. 69."Shipping list no.: 94-0020-P.Distributed to some depository libraries in microfiche.Mode of...

FDA consumer protection activities--FDA reorganization. Hearings, Ninety-first Congress, first and second session ...

United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Public Health and Welfare.

January 1970

Hearings held Aug. 12, 1969-Jan. 29, 1970."Serial no. 91-71."Includes bibliographical references.Mod...

FDA regulation of medical devices, including the status of breast implants : joint hearing before the Subcommittee on Human Resources and Intergovernmental Relations and the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 1, 1995.

United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations.
United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs.

Shipping list no.: 96-0129-P.Distributed to some depository libraries in microfiche.Cover title.Incl...

Clinical laboratories : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session ....

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 102-136"--Pt. 2."Serial no. 102-67"--Pt. [1].Shipping list no.: 92-167-P.Distributed to ...

Biotechnology development : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first session, December 18, 1985.

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.

"Serial no. 99-53.""Printed for the use of the Committee on Energy and Commerce."Mode of access: Int...

Medical devices : FDA can improve oversight of tracking and recall systems : report to the Subcommittee on Oversight and Investigations, Committee on Commerce, House of Representatives /

United States. General Accounting Office.
United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.

"September 1998"GAO/HEHS-98-211."Cover title.Includes bibliographical references.Mode of access: Int...

FDA medical product approvals : hearing before the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 8, 1995.

United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs.

January 1997

Shipping list no.: 97-0171-P.Distributed to some depository libraries in microfiche.Mode of access: ...

FDA and the medical device industry : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, second session, February 26, 1990.

Abstract

Extracted data

FDA and the medical device industry : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, second session, February 26, 1990.

Abstract

Extracted data

Topics

Related items

Topics

Related items